Vistagen Therapeutics, Inc. (VTGN)

0.6859 +0.02 (+3.63%) USD  |  NASDAQ  |  Jan 02, 14:25
More

Vistagen Therapeutics Revenue Estimates for Next Quarter

Revenue Estimates for Next Quarter Chart

View Revenue Estimates for Next Quarter for VTGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Revenue Estimates for Next Quarter Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Revenue Estimates for Next Quarter Range, Past 5 Years

View Revenue Estimates for Next Quarter Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Revenue Estimates for Next Quarter Benchmarks

View Revenue Estimates for Next Quarter Benchmarks
Start Trial
Vanda Pharmaceuticals, Inc. Upgrade
XOMA Royalty Corp. Upgrade
Omeros Corp. Upgrade
GeoVax Labs, Inc. Upgrade
Daré Bioscience, Inc. Upgrade

Revenue Estimates for Next Quarter Related Metrics

Revenue Estimates for Current Quarter Upgrade
Revenue Estimates for Current Fiscal Year Upgrade
Revenue Estimates for Next Fiscal Year Upgrade
EPS Estimates for Current Quarter Upgrade
EPS Estimates for Next Quarter Upgrade
EPS Estimates for Current Fiscal Year Upgrade
EPS Estimates for Next Fiscal Year Upgrade